MindMed: Rethinking brain health with psychedelic therapy скачать в хорошем качестве

MindMed: Rethinking brain health with psychedelic therapy

Over the last 18 months, MindMed has undergone an extraordinary transformation. It released compelling data for its LSD-based drug MM120, followed by FDA breakthrough designation for MM120 for the treatment of GAD, and strong financial backing. CEO Rob Barrow outlines the company's ambitious goals and the path to potentially transforming mental healthcare at RBC's Global Healthcare Conference. Follow us on LinkedIn: http://spr.ly/6055PcIPN Follow us on X: http://spr.ly/6056PcIP4 For information on our legal terms of use visit: http://spr.ly/6057PcIPf About RBC Capital Markets – An Innovative, Trusted Partner RBC Capital Markets is recognized by the most significant corporations, institutional investors, asset managers, private equity firms, and governments around the globe as an innovative, trusted partner with an in-depth expertise in capital markets, banking, and finance. We are well-established in the largest, most mature capital markets across North America, Europe, and the Asia-Pacific region, which collectively encompass more than 75% of global investment banking activity each year. About Royal Bank of Canada We are part of Royal Bank of Canada (RBC), a leading, diversified provider of financial services and one of the strongest banks globally. Founded in 1864, RBC is the 10th largest bank worldwide and the 5th in North America, as measured by market capitalization. RBC is among a small group of highly rated global banks and is recognized time and time again for its financial strength, market leadership and philanthropic work. For information on our legal terms of use visit: http://spr.ly/6050GGRH2